Metraipolis › archive › dc_fe1be1cfbe93
A Retrospective Study of Rabbit Anti-T Lymphocyte Globulin (rATLG) as a Second-Line Therapy in Transplant-Ineligible Severe Aplastic Anemia Patients — Europe PMC PMID:41466957
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41466957
- DOI
- 10.7759/cureus.98014
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-08T04:26:21.397Z
- SHA-256 of the archived text
38805083dbc4743d895e0de401b67a0c6311fda6810ae9b528a70c273a5199f4- Stable URL of this page
https://metraipolis.com/documento/dc_fe1be1cfbe93
How to cite
A Retrospective Study of Rabbit Anti-T Lymphocyte Globulin (rATLG) as a Second-Line Therapy in Transplant-Ineligible Severe Aplastic Anemia Patients — Europe PMC PMID:41466957 — Europe PMC (en), https://europepmc.org/article/MED/41466957 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fe1be1cfbe93 (Metraipolis archive dc_fe1be1cfbe93, sha256 38805083dbc4743d895e0de401b67a0c6311fda6810ae9b528a70c273a5199f4)
BibTeX
@misc{dcfe1be1cfbe93,
title = {A Retrospective Study of Rabbit Anti-T Lymphocyte Globulin (rATLG) as a Second-Line Therapy in Transplant-Ineligible Severe Aplastic Anemia Patients — Europe PMC PMID:41466957},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41466957},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fe1be1cfbe93; sha256 38805083dbc4743d895e0de401b67a0c6311fda6810ae9b528a70c273a5199f4},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41466957. Agents can read the archived copy with the MCP tool read_document.